Abstract
From routine therapeutic drug monitoring data, samples from 105 patients with two analyses of nortriptyline at different daily doses were collected. The ratio between concentration and daily dose, which is the reciprocal of the apparent clearance, was compared intra-individually to study the occurrence of dose-dependent kinetics.
Subjects with a low or intermediate ratio at the low dose had a higher mean ratio at the high dose, indicating a nonlinear relationship between dose and concentration. The magnitude of the difference was inversely correlated to the ratio at the low dose. No major difference was seen in the ca. 10% of the patients that exhibited the highest ratio at the low dose. This fraction corresponds to the frequency of poor metabolizers of debrisoquine in the population. The metabolism of nortriptyline has been shown to be partly dependent on the debrisoquine hydroxylase CYP2D6.
We conclude that dose-dependent kinetics of nortriptyline occurs in subjects with a high or intermediate capacity to eliminate the drug, in accord with debrisoquine hydroxylase being a high-affinity, low-capacity pathway in the elimination of nortriptyline.
Similar content being viewed by others
References
Ludden TM (1991) Nonlinear pharmacokinetics, clinical implications. Clin Pharmacokinet 20: 429–446
Tsuchiya T, Levy G (1972) Relationship between dose and plateau levels of drugs eliminated by parallel first-order and capacity-limited kinetics. J Pharmacol Sci 61: 541–544
Bjerre M, Gram LF, Kragh-Sørensen P, Kristensen CB, Pedersen OL, Møller M, Thayssen P (1981) Dose-dependent kinetics of imipramine in elderly patients. Psychopharmacology 75: 354–357
Brøsen K, Gram LF, Klysner R, Bech P (1986) Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics. Eur J Clin Pharmacol 30: 43–49
Sindrup SH, Brøsen K, Gram LF (1992) Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: nonlinearity and relation to the sparteine oxidation polymorphism. Clin Pharmacol Ther 51: 288–295
Vandel S, Bertschy G, Vandel B, Allers G, Volmat R (1989) Amitriptyline: linear or nonlinear kinetics in everyday practice? Eur J Clin Pharmacol 37: 595–598
Vandel S, Bertschy G, Vandel B, Allers G, Volmat R (1990) Non-linear kinetics of nortriptyline in everyday practice. Eur J Clin Pharmacol 39: 97–98
Bertilsson L, Eichelbaum M, Mellström B, Säwe J, Schultz H-U, Sjöqvist F (1980) Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man. Life Sci 27: 1673–1677
Sheiner LB, Beal SL (1981) Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 9: 503–512
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jerling, M., Alván, G. Nonlinear kinetics of nortriptyline in relation to nortriptyline clearance as observed during therapeutic drug monitoring. Eur J Clin Pharmacol 46, 67–70 (1994). https://doi.org/10.1007/BF00195918
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00195918